Business Description
Aarey Drugs & Pharmaceuticals Ltd
NAICS : 325412
ISIN : INE198H01019
Share Class Description:
BOM:524412: Shs DematerialisedCompare
Compare
Traded in other countries / regions
AAREYDRUGS.India IPO Date
1994-02-23Description
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 2.75 | |||||
Interest Coverage | 0.63 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.32 | |||||
Beneish M-Score | -2.11 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.8 | |||||
3-Year EBITDA Growth Rate | -6.2 | |||||
3-Year EPS without NRI Growth Rate | -13 | |||||
3-Year Book Growth Rate | 3.8 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 57.44 | |||||
9-Day RSI | 51.92 | |||||
14-Day RSI | 49.35 | |||||
6-1 Month Momentum % | 0.48 | |||||
12-1 Month Momentum % | 51.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.68 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 27.36 | |||||
Days Sales Outstanding | 148.78 | |||||
Days Payable | 101.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -2.55 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 3.47 | |||||
Operating Margin % | 0.7 | |||||
Net Margin % | 1.41 | |||||
FCF Margin % | -0.83 | |||||
ROE % | 4.53 | |||||
ROA % | 2.01 | |||||
ROIC % | 1.72 | |||||
ROC (Joel Greenblatt) % | 7.36 | |||||
ROCE % | 7.59 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 21.64 | |||||
PE Ratio without NRI | 21.69 | |||||
Shiller PE Ratio | 16.75 | |||||
PS Ratio | 0.36 | |||||
PB Ratio | 1 | |||||
Price-to-Tangible-Book | 1 | |||||
EV-to-EBIT | 16.61 | |||||
EV-to-EBITDA | 14.14 | |||||
EV-to-Revenue | 0.41 | |||||
EV-to-FCF | -48.88 | |||||
Price-to-Projected-FCF | 1.82 | |||||
Price-to-Median-PS-Value | 1.79 | |||||
Price-to-Graham-Number | 0.98 | |||||
Price-to-Net-Current-Asset-Value | 1.2 | |||||
Earnings Yield (Greenblatt) % | 6.02 | |||||
FCF Yield % | -2.48 | |||||
Forward Rate of Return (Yacktman) % | -3.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aarey Drugs & Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 3,956.179 | ||
EPS (TTM) (₹) | 2.19 | ||
Beta | 1.03 | ||
Volatility % | 42.82 | ||
14-Day RSI | 49.35 | ||
14-Day ATR (₹) | 2.059405 | ||
20-Day SMA (₹) | 46.367 | ||
12-1 Month Momentum % | 51.33 | ||
52-Week Range (₹) | 30 - 68 | ||
Shares Outstanding (Mil) | 28.05 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aarey Drugs & Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aarey Drugs & Pharmaceuticals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Aarey Drugs & Pharmaceuticals Ltd Frequently Asked Questions
What is Aarey Drugs & Pharmaceuticals Ltd(BOM:524412)'s stock price today?
The current price of BOM:524412 is ₹47.39. The 52 week high of BOM:524412 is ₹68.00 and 52 week low is ₹30.00.
When is next earnings date of Aarey Drugs & Pharmaceuticals Ltd(BOM:524412)?
The next earnings date of Aarey Drugs & Pharmaceuticals Ltd(BOM:524412) is .
Does Aarey Drugs & Pharmaceuticals Ltd(BOM:524412) pay dividends? If so, how much?
Aarey Drugs & Pharmaceuticals Ltd(BOM:524412) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |